HTR3E Gene

HTR3E Gene

<div class="infobox infobox-gate">
<h3>HTR3E</h3>
<table>
<tr><th>Symbol</th><td>HTR3E</td></tr>
<tr><th>Full Name</th><td>5-Hydroxytryptamine Receptor 3E</td></tr>
<tr><th>Chromosomal Location</th><td>3q27.1</td></tr>
<tr><th>NCBI Gene ID</th><td>127293</td></tr>
<tr><th>OMIM ID</th><td>608679</td></tr>
<tr><th>Ensembl ID</th><td>ENSG00000181191</td></tr>
<tr><th>UniProt ID</th><td>Q9ERQ1</td></tr>
<tr><th>Protein Size</th><td>465 amino acids</td></tr>
<tr><th>Protein Family</th><td>Cys-loop ligand-gated ion channel superfamily</td></tr>
<tr><th>Expression</th><td>Peripheral tissues (GI tract), enteric nervous system, limited brain expression</td></tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">1 edges</a></td>
</tr>
</table>
</div>

Overview

HTR3E (5-Hydroxytryptamine Receptor 3E) encodes an auxiliary subunit of the 5-HT3 receptor, a ligand-gated ion channel that mediates fast serotonergic signaling. Unlike the core HTR3A subunit that is absolutely required for functional receptor formation, the HTR3E subunit functions as a modulatory component that can be incorporated into heteromeric 5-HT3 receptor complexes to alter their pharmacological and biophysical properties[@br南海2011].

HTR3E Gene

<div class="infobox infobox-gate">
<h3>HTR3E</h3>
<table>
<tr><th>Symbol</th><td>HTR3E</td></tr>
<tr><th>Full Name</th><td>5-Hydroxytryptamine Receptor 3E</td></tr>
<tr><th>Chromosomal Location</th><td>3q27.1</td></tr>
<tr><th>NCBI Gene ID</th><td>127293</td></tr>
<tr><th>OMIM ID</th><td>608679</td></tr>
<tr><th>Ensembl ID</th><td>ENSG00000181191</td></tr>
<tr><th>UniProt ID</th><td>Q9ERQ1</td></tr>
<tr><th>Protein Size</th><td>465 amino acids</td></tr>
<tr><th>Protein Family</th><td>Cys-loop ligand-gated ion channel superfamily</td></tr>
<tr><th>Expression</th><td>Peripheral tissues (GI tract), enteric nervous system, limited brain expression</td></tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">1 edges</a></td>
</tr>
</table>
</div>

Overview

HTR3E (5-Hydroxytryptamine Receptor 3E) encodes an auxiliary subunit of the 5-HT3 receptor, a ligand-gated ion channel that mediates fast serotonergic signaling. Unlike the core HTR3A subunit that is absolutely required for functional receptor formation, the HTR3E subunit functions as a modulatory component that can be incorporated into heteromeric 5-HT3 receptor complexes to alter their pharmacological and biophysical properties[@br南海2011].

The 5-HT3 receptor family consists of five subunits (HTR3A through HTR3E), with HTR3A being the primary subunit that forms functional homomeric receptors. HTR3E, along with HTR3B, HTR3C, and HTR3D, can combine with HTR3A to form heteromeric receptors with distinct properties. HTR3E is particularly notable for its high expression in peripheral tissues, especially the gastrointestinal tract, where it plays important roles in gut motility, secretion, and visceral sensation.

This page provides comprehensive information on the HTR3E gene, including its molecular biology, physiological functions, disease associations, and therapeutic relevance.

Gene Structure and Evolution

Genomic Organization

The HTR3E gene is located on chromosome 3q27.1, within a cluster of 5-HT3 receptor subunit genes on the long arm of chromosome 3. This genomic region underwent duplication events during evolution, creating a family of related genes with distinct expression patterns and functions.

The HTR3E gene shares significant sequence homology with other 5-HT3 subunits, particularly in the conserved regions encoding the transmembrane domains and the Cys-loop motif. However, the extracellular N-terminal domain shows sufficient divergence to confer distinct pharmacological properties.

Evolutionary Context

The 5-HT3 receptor family evolved from an ancestral nicotinic acetylcholine receptor-like gene through a series of gene duplication events. The emergence of distinct subunit types (A-E) allowed for greater diversity in receptor properties, enabling fine-tuning of serotonergic signaling across different tissues and physiological contexts.

Protein Structure and Function

Structural Organization

The HTR3E protein, like other Cys-loop receptor subunits, contains:

Receptor Assembly and Pharmacology

HTR3E cannot form functional homomeric receptors—it requires co-assembly with HTR3A to produce functional channels. When incorporated into heteromeric receptors, HTR3E modulates several properties[@kelley2020]:

Pharmacological Modulation

• Agonist Affinity: May alter the affinity for serotonin and other agonists
• Antagonist Sensitivity: Different sensitivity to selective antagonists
• Allosteric Modulation: Unique binding sites for allosteric modulators

Biophysical Properties

• Single-Channel Conductance: Alters channel conductance properties
• Desensitization Kinetics: Modulates the rate and extent of receptor desensitization
• Recovery from Desensitization: Affects the time course of receptor recovery
• Open Probability: Influences channel open probability

Trafficking and Localization

• Cell Surface Expression: May affect the efficiency of receptor trafficking to the membrane
• Subcellular Localization: Can influence the subcellular distribution of receptors

Expression Patterns

Gastrointestinal Tract

HTR3E shows highest expression in the gastrointestinal tract[@holzer2018; @kee2019]:

• Enteric Nervous System: High expression in both myenteric and submucosal plexuses
• Smooth Muscle: Presence in circular and longitudinal muscle layers
• Epithelial Cells: Expression in intestinal epithelial cells
• Enterochromaffin Cells: The serotonin-producing cells of the gut

Central Nervous System

In contrast to HTR3A, HTR3E expression in the brain is relatively limited:

• Specific Brain Regions: Low to moderate expression in certain areas
• Neuronal Types: Primarily in non-serotonergic neurons
• Glial Cells: Some evidence for expression in astrocytes

Other Tissues

• Immune Cells: Expression in monocytes and macrophages[@steiger2020]
• Cardiovascular System: Low expression in some cardiovascular tissues
• Endocrine Tissues: Minor expression in some endocrine organs

Normal Physiological Functions

Gastrointestinal Motility

HTR3E plays a crucial role in regulating gut motility[@camilleri2016]:

• Peristalsis: 5-HT3 receptors containing HTR3E contribute to the coordination of peristaltic waves
• Transit Time: Modulates the speed of intestinal transit
• Defecation: Involved in regulating defecation reflexes

Visceral Sensation

HTR3E contributes to visceral sensation and pain processing:

• Vagal Afferents: 5-HT3 receptors on vagal afferents detect gut signals
• Spinal Afferents: Modulates signaling from spinal afferents to the CNS
• Visceral Hypersensitivity: Relevant to conditions like IBS

Secretion

5-HT3 receptors influence gastrointestinal secretions:

• Chloride Secretion: Modulates intestinal chloride secretion
• Fluid Balance: Affects fluid movement across the intestinal epithelium
• Mucus Production: May influence mucus secretion

Immune Function

In immune cells, 5-HT3 receptors (including those with HTR3E) have immunomodulatory functions[@schiavone2020]:

• Cytokine Release: Modulates cytokine production
• Migration: Affects immune cell migration
• Phagocytosis: Influences phagocytic activity

Role in Disease and Disorders

Irritable Bowel Syndrome (IBS)

HTR3E has been implicated in IBS pathophysiology[@gaddi2017; @chen2017]:

• Visceral Hypersensitivity: HTR3E variants associated with increased visceral pain
• Gut Motility: Altered function may contribute to abnormal motility patterns
• Gut-Brain Axis: Modulates communication between gut and brain
• Microbiome Interactions: Potential interactions with gut microbiota

Functional Gastrointestinal Disorders

HTR3E variations have been associated with:

• Functional Dyspepsia: Altered gastric emptying and sensation
• Functional Constipation: Changes in colonic motility
• Functional Diarrhea: Altered intestinal transit

Chemotherapy-Induced Nausea and Vomiting (CINV)

While the primary antiemetic effects are mediated through HTR3A-containing receptors, HTR3E may contribute to:

• Individual Variation: Genetic variability in treatment response
• Side Effects: Potential contribution to adverse effects

Inflammatory Conditions

HTR3E may play roles in inflammatory conditions:

• Inflammatory Bowel Disease: Potential involvement in gut inflammation
• Colitis: Animal models suggest protective roles

Neurological Implications

Though brain expression is limited, HTR3E may have neurological functions:

• Nociception: Modulation of pain pathways
• Mood Disorders: Potential indirect effects on serotonergic circuitry

Therapeutic Targeting

Clinical Applications

Gastrointestinal Disorders

5-HT3 antagonists (primarily targeting HTR3A) are used for:

• Irritable Bowel Syndrome: Alosetron (for diarrhea-predominant IBS)
• Functional GI Disorders: Various off-label uses

Chemotherapy-Induced Nausea

5-HT3 antagonists are first-line antiemetics:

• Ondansetron: Most widely used
• Granisetron: Alternative option
• Palonosetron: Longer duration of action

Drug Development

Novel approaches targeting 5-HT3 receptors with HTR3E involvement include[@johnson2018]:

• Subtype-Selective Ligands: Developing compounds that selectively target heteromeric receptors containing HTR3E
• Allosteric Modulators: Targeting allosteric sites specific to HTR3E-containing receptors
• Gut-Restricted Compounds: Developing drugs that act primarily in the GI tract to minimize CNS effects

Pharmacogenomics

Genetic variation in HTR3E may influence[@olesen2012]:

• Drug Response: Individual variation in 5-HT3 antagonist efficacy
• Adverse Effects: Susceptibility to side effects
• Disease Risk: Genetic associations with GI disorders

Research Methods

Molecular Biology

• RT-PCR: Detection of HTR3E mRNA
• In situ hybridization: Anatomical localization
• Western blot: Protein expression analysis

Electrophysiology

• Voltage-clamp: Functional characterization of heteromeric receptors
• Single-channel recording: Kinetics of HTR3E-containing receptors

Imaging

• Immunohistochemistry: Protein localization
• Confocal microscopy: Subcellular distribution

Behavioral Models

• Gut Motility Studies: Transit and motility measurements
• Visceral Pain Models: Visceral sensitivity testing

Cross-Linking and Related Topics

For more information, see:

• [5-HT3 Receptor Protein](/proteins/htr3a-protein)
• [HTR3D Gene](/genes/htr3d)
• [HTR3A Gene](/genes/htr3a)
• [HTR3C Gene](/genes/htr3c)
• [Serotonin Signaling](/mechanisms/serotonin-signaling)
• [Enterochromaffin Cells](/cell-types/enterochromaffin-cells)
• [Irritable Bowel Syndrome](/diseases/irritable-bowel-syndrome)
• [Gut-Brain Axis](/mechanisms/psychobiotic-therapy-neurodegeneration)
• [GPCR Signaling](/mechanisms/gpcr-signaling)

Summary

The HTR3E gene encodes an auxiliary subunit of the 5-HT3 receptor that modulates the properties of heteromeric receptor complexes. Unlike the core HTR3A subunit, HTR3E cannot form functional receptors on its own but contributes to receptor diversity when incorporated into complexes with HTR3A.

The primary functions of HTR3E-containing receptors are in the gastrointestinal tract, where they regulate motility, secretion, and visceral sensation. This makes them relevant to conditions like irritable bowel syndrome and functional GI disorders. HTR3E variants have been associated with altered visceral sensitivity and may influence individual responses to 5-HT3 antagonist therapies.

Understanding the specific roles of HTR3E in receptor function continues to inform drug development efforts, with the goal of creating more targeted therapies for GI and possibly neurological conditions. The gut-restricted expression of HTR3E offers opportunities for developing drugs with minimal CNS effects.

External Links

• [NCBI Gene: HTR3E](https://www.ncbi.nlm.nih.gov/gene/127293)
• [UniProt: Q9ERQ1](https://www.uniprot.org/uniprot/Q9ERQ1)
• [Ensembl: ENSG00000181191](https://www.ensembl.org/Homo_sapiens/Gene?g=ENSG00000181191)
• [GeneCards: HTR3E](https://www.genecards.org/cgi-bin/carddisp.pl?gene=HTR3E)

References